Skip to main content

Postbiotic

unknown (auto-discovered: incretin-obesity)

Classification

Supplement

Regulatory Status

investigational; registered trials: NCT07903870 (EARLY_PHASE1)

Unofficial source

Sources

1

Review

pending review

Overview

Unknown — Postbiotic was found by open discovery on 2026-10-30 and has not been researched yet.

Evidence and limitations

Known

n/a

Unknown

  • Mechanism, dosing, safety, interactions and efficacy are unknown until research runs on this auto-discovered draft.
Study details: trial conditions, not guidance

These are the conditions researchers used in a controlled trial with medical supervision. They aren't instructions.

Doses found

Doses as found in each source, with its grade. What was found, not a direction.

Studies, trials and professional sources

n/a

Reddit, Facebook, Instagram, forums and blogs

n/a

Claims and grades

  • Not gradedPostbiotic is being studied in a registered trial: Efficacy of the pA1c®HI Postbiotic in Metabolic Regulation in Healthy Individuals With Hyperglycemia (NCT07903870; EARLY_PHASE1; NOT_YET_RECRUITING; sponsor Genbioma Aplicaciones SL; intervention "Postbiotic" (DIETARY_SUPPLEMENT)).

Sources (1)

Educational reference only — not medical advice.

What people report (anecdote)

CLINICAL DATA (from trials)

Adverse events:

None recorded in our sources.

Effects measured:

Human trials: none found.

ANECDOTE

What people report: anecdote, not evidence

Loading…

Submit a claim you saw
Postbiotic: what the evidence actually says | BioStack